Delivery Order SPE2DR25D1053-SPE2DR26FT718
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,114.64 for 100-unit vials of Xeomin on September 18, 2025, with completion scheduled for October 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used for neurological and aesthetic applications. This firm fixed price, non-set-aside contract was awarded on October 27, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,524.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 unit vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract is being performed at the awardee's Conshohocken, Pennsylvania location and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $5,587.40 and an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $5,989.62 and an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Xeomin 100 unit vials, with a ceiling value of $1,676.22 and a firm fixed price structure. The order is expected to be completed by November 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Xeomin 200 unit vials, with a ceiling value of $13,409.76 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 20, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT718Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $17,664.60 and a firm fixed price contract structure. This is a non-set-aside delivery order with an ultimate completion date of December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning it as a key vendor in the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/7/25 |